期刊文献+

生长抑素治疗肝癌的机制及其临床应用

下载PDF
导出
摘要 近年的研究表明用生长抑素 (SS)治疗肝癌等实体瘤具有潜在的应用前景。本文就SS治疗肝癌的作用机制及其临床应用作一综述。
出处 《汕头大学医学院学报》 2004年第4期240-242,共3页 Journal of Shantou University Medical College
  • 相关文献

参考文献28

  • 1Patel YC,Srikant CB.Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors(hsstr1-5)[J].Endocrinology,1994,135(6):2814-2817.
  • 2Fiebiger WC,Scheithauer W,Traub T,et al.Absence of therapeutic efficacy of the somatostatin analogue lanreotide in advanced primary hepatic cholangiocellular cancer and adenocarcinoma of the gallbladder despite in vivo somatostatin-receptor expression[J].Scand J Gastroenterol,2002,37:222-225.
  • 3Dimitroulopoulos D,Xinopoulos D,Tsamakidis K,et al.The role of sandostatin LAR in treating patients with advanced hepatocellular cancer[J].Hepatogastroenterology,2002,49:1245-1250.
  • 4Kouroumalis E,Skordilis P,Thermos K,et al.Treatment of hepatocellular carcinoma with octreotide:a randomised controlled study[J].Gut,1998,42:442-447.
  • 5Eden PA,Taylor JE.Somatostatin receptor subtype gene expression in human and rodent tumors[J].Life Sci,1993,53: 85-90.
  • 6Reubi JC,Zimmermann A,Jonas S,et al.Regulatory peptide receptors in human hepatocellular carcinomas[J].Gut,1999,45:766-774.
  • 7颜登国,区庆嘉.生长抑素受体亚型SSTR-2和SSTR-3mRNA在原发性肝癌中的表达[J].癌症,2001,20(2):152-155. 被引量:14
  • 8刘建生,彭淑牖,吴育莲,彭承宏,陈怀增,Gao YY.人类生长抑素受体mRNA在原发性肝癌中的表达[J].中华消化杂志,2002,22(11):683-683. 被引量:6
  • 9Bruno JF,Xu Y.Tissue distribution of somatostatin receptor subtype messenger robonucleic acid in the rat[J].Endocrinology,1993,33:2561-2567.
  • 10Theveniau MA,Yasuda K,Bell GI,et al.Immunological detection of isomorfs of the somatostatin receptor Subtype,SSTR2[J].F Neruochem,1994,63:447-455.

二级参考文献20

  • 1杨继金,朱永法.大白鼠转移性肝癌模型的制作[J].中华放射学杂志,1993,27(2):122-123. 被引量:42
  • 2Thangaraju M,Cancer Res,1999年,59卷,1649页
  • 3Bonin S, Pascolo L, Croce LS, et al. Gene expression of ABC proteins in hepatocellular carcinoma, perineoplastic tissue, and liver diseases. Mol Med, 2002, 8:318-325.
  • 4Nies AT, Konig J, Pfannschmidt M, et al. Expression of the multidrug resistance proteins MRP2 and MRP3 in human hepatocellular carcinoma. Iht J Cancer, 2001, 15: 94:492-499.
  • 5Romani R, Morris DL. SMS 201. 995 Sandostatin enhances in-vitro effects of 5-fluorouracil in colorectal cancer. Eur J Surg Oncol,1995,21:27-32.
  • 6Szende B, Horvath A, Bokonyi G, et al. Effect of a novel somatostatin analogue combined with cytotoxic drugs on human tumour xenografts and metastasis of B16 melanoma. Br J Cancer, 2003,88:132-136.
  • 7SchallyAV.Oncologicalapplicationsofsomatostatinanalogus[J][].CancerRes.1988
  • 8StevenWJ,AartJanDL,WouterWDetal.Drugtherapy:Octreotide[J][].TheNewEnglandJournalofMedicine.1996
  • 9KouroumalisE,SkordilisP,ThermosKetal.Treatmentofhepatocellularcarcinomawithoctreotide:arandomisedcontrolledstudy[J][].Gut.1998
  • 10KubotaA,YamadaY,KagimotoSetal.IdentificationofsomatostatinreceptorsubtypesandanimplicationfortheefficacyofsomatostatinanalogueSMS201995intreatmentofhumanendocrinetumors[J][].JofClinInvest.1994

共引文献78

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部